Blood gas and electrolyte analyzers are used to extract several parameters from whole blood samples, including pH, electrolytes, blood gas (pCO2 and pO2), and metabolites. The pH of blood and plasma or serum is an indication of the balance of the renal (kidney), blood, and lung systems. Where the pCO2 value of arterial blood is employed to gain access to effective carbon dioxide removal from the body. Whereas a byproduct of metabolism and the pO2 value in arterial blood is a measure of the body's oxygen absorption in the lungs. Electrolytes and metabolites provide further information about the body's metabolism.
Furthermore, an increase in the number of patients treated in NICUs, ICUs, and emergency departments increases the demand for blood gas and electrolyte analyzers. In addition, the market for blood gas and electrolyte analyzers is expanding as a result of an increase in patients suffering from chronic illnesses and cancer development. Furthermore, advancements in blood gas and electrolyte analyzers, as well as an increase in product approvals, are significant drivers favoring the growth of the blood gas and electrolyte analyzers market. However, the intricacy involved in the interpretation of blood analysis data acts as a detriment to the market's growth.
Increased age is a high-risk factor for cancer growth and chronic illnesses, necessitating regular blood gas testing and point of care (POC) diagnostic assessment, which predicts an increase in the blood gas and electrolyte market. According to the World Health Organization, approximately 3 million deaths were caused by chronic diseases globally in 2015, accounting for 5% of all deaths globally in that year, resulting in a significant increase in the traffic of emergency cases, creating a huge demand for blood gas and electrolyte analyzers. Furthermore, the world population aged 65 and over is expected to rise by 5% in 2015, resulting in a significant increase in the demand for blood gas and electrolyte analyzers.